Pay in 4 interest-free payments of $2.50 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
$12 million in 2024 spending
Partnership Type 2024 Goal Impact Biotech Alliances Secure 2-3 Licensing deals $30M in upfront payments Research Institution Increase Research Projects by 10% 10 new drug targets identified CRO Collaboration Reduce trial timeline by 10% $15M in cost savings
cutting verification time from days to minutes and lowering onboarding drop-off by up to 40% (industry avg
This approach directly addresses the core needs of patients
This strategic tool dissects their customer segments
CONMED BUSINESS MODEL CANVAS TEMPLATE RESEARCH B_139 $12 million in 2024 spendingCONMED Business Model Canvas: How the Medtech Leader Wins Unlock the full strategic blueprint behind CONMED's business model this concise Business Model Canvas maps customer segments, value props, key partners, revenue streams, and cost drivers so you can see how CONMED wins in medtech. Partnerships Strategic GPO Agreements with Vizient and Premier CONMED's strategic GPO agreements with Vizient and Premier grant institutional access to over 90% of US
